4-(2-AMINOETHYL)-5-(4-FLUOROPHENYL)-1,2-DIHYDRO-3H-PYRAZOL-3-ONE
- $120 - $452
- Product name: 4-(2-AMINOETHYL)-5-(4-FLUOROPHENYL)-1,2-DIHYDRO-3H-PYRAZOL-3-ONE
- CAS: 878208-78-7
- MF: C11H12FN3O
- MW: 221.23
- EINECS:
- MDL Number:MFCD06653447
- Synonyms:4-(2-AMINOETHYL)-5-(4-FLUOROPHENYL)-1,2-DIHYDRO-3H-PYRAZOL-3-ONE;4-(2-AMINOETHYL)-5-(4-FLUOROPHENYL)-1H-PYRAZOL-3(2H)-ONE;3H-Pyrazol-3-one, 4-(2-aminoethyl)-5-(4-fluorophenyl)-1,2-dihydro-;4-(2-Aminoethyl)-3-(4-fluorophenyl)-1H-pyrazol-5-ol
4 prices
Selected condition:
Brand
- Chemenu
- Crysdot
- TRC
Package
- 10mg
- 50mg
- 250mg
- ManufacturerChemenu
- Product numberCM314496
- Product description4-(2-Aminoethyl)-5-(4-fluorophenyl)-1H-pyrazol-3(2H)-one 95%
- Packaging250mg
- Price$426
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD11037193
- Product description4-(2-Aminoethyl)-5-(4-fluorophenyl)-1H-pyrazol-3(2H)-one 95+%
- Packaging250mg
- Price$452
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberA608065
- Product description4-(2-Aminoethyl)-5-(4-fluorophenyl)-1,2-dihydro-3h-pyrazol-3-one
- Packaging10mg
- Price$120
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberA608065
- Product description4-(2-Aminoethyl)-5-(4-fluorophenyl)-1,2-dihydro-3h-pyrazol-3-one
- Packaging50mg
- Price$375
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Chemenu | CM314496 | 4-(2-Aminoethyl)-5-(4-fluorophenyl)-1H-pyrazol-3(2H)-one 95% | 250mg | $426 | 2021-12-16 | Buy |
Crysdot | CD11037193 | 4-(2-Aminoethyl)-5-(4-fluorophenyl)-1H-pyrazol-3(2H)-one 95+% | 250mg | $452 | 2021-12-16 | Buy |
TRC | A608065 | 4-(2-Aminoethyl)-5-(4-fluorophenyl)-1,2-dihydro-3h-pyrazol-3-one | 10mg | $120 | 2021-12-16 | Buy |
TRC | A608065 | 4-(2-Aminoethyl)-5-(4-fluorophenyl)-1,2-dihydro-3h-pyrazol-3-one | 50mg | $375 | 2021-12-16 | Buy |
Properties
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|